RxDoctor Payments Data

Rachael Light, DO

Family Medicine · Richmond, VANPI 1861755746

Payments from drug & device makers

$2,018in general payments, 2019–2025

Across 124 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$407
  • Lilly USA, LLC$333
  • Exact Sciences$237
  • AbbVie$167
  • Bayer$159
  • Novartis$112
  • plus $603 from 16 others

What the payments were for

  • Food & beverage$2,018100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,018 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$50,796
Medicare patients
254
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin45$54,864
OzempicSemaglutide33$44,496
MounjaroTirzepatide30$31,927
RybelsusSemaglutide13$19,337
EliquisApixaban25$16,128
XareltoRivaroxaban17$11,365
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,815
Tresiba Flextouch U-100Insulin Degludec16$6,884
DuleraMometasone/Formoterol11$3,880
Atorvastatin Calcium314$2,517
Levothyroxine Sodium223$2,186
Metoprolol Succinate98$1,433
Rosuvastatin Calcium150$1,419
Wixela InhubFluticasone Propion/Salmeterol19$1,362
Nano 2nd Gen Pen NeedlePen Needle, Diabetic18$1,279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$407$63,83246 claims
Boehringer IngelheimJardiance$13$54,86445 claims
Lilly USA, LLCMounjaro$333$31,92730 claims
PfizerEliquis$82$16,12825 claims
AbbVieSynthroid$167$1,27831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →